Location of Repository

Cancer and fertility preservation: fertility preservation in breast cancer patients

By Theodoros Maltaris, Michael Weigel, Andreas Mueller, Marcus Schmidt, Rudolf Seufert, Franz Fischl, Heinz Koelbl and Ralf Dittrich

Abstract

Aggressive chemotherapy has improved the life expectancy for reproductive-age women with breast cancer, but it often causes infertility or premature ovarian failure due to destruction of the ovarian reserve. Many questions concerning fertility preservation in breast cancer patients remain unanswered – for example, whether fertility preservation methods interfere with chemotherapy, and whether subsequent pregnancy has negative effects on the prognosis. Fertility preservation is a critical factor in decision-making for younger breast cancer patients, however, and clinicians should address this. The present article reviews the incidence of chemotherapy-induced amenorrhea, and discusses fertility-preservation options and the prognosis for patients who become pregnant after breast cancer

Topics: Review
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2397531
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2007). Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist
    2. (2005). Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment.
    3. (2002). Adjuvant therapy for premenopausal women with breast cancer: is it time for another paradigm shift?
    4. (1997). Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications. Breast Cancer Res Treat
    5. ATAC Trialists’ Group: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet
    6. (2005). Bedaiwy MA: Fertility preservation and pregnancy outcome after malignancy. Curr Opin Obstet Gynecol
    7. (2000). Blomqvist C: Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.
    8. (2002). Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control
    9. (2005). Chemotherapy-induced amenorrhea is increased in patients treated with adjuvant doxorubicin and cyclophosphamide (AC) followed by a taxane (T). ASCO annual meeting proceedings.
    10. (2006). Cil AP, Bang H: Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril
    11. (2007). Comparison of xenografting in SCID mice and LIVE/DEAD assay as a predictor of the developmental potential of cryopreserved ovarian tissue.
    12. (2007). Current status of adjuvant endocrine therapy for premenopausal patients with primary breast cancer [abstract]. Breast Cancer Res
    13. (1977). Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer
    14. (2003). Daling JR: Childbearing and survival after breast carcinoma in young women. Cancer
    15. (1992). Das Gupta TK: Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat
    16. (2005). DM: Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes. Clin Breast Cancer
    17. (2005). Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
    18. (2005). E: Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data.
    19. (2006). E: The impact of treatment-induced amenorrhea on survival of premenopausal patients with endocrine responsive breast cancer: 10-year result of ABCSG-05 (CMF vs. goserelin + tamoxifen) [abstract]. Breast Cancer Res Treat
    20. (2005). EP: Fertility after breast cancer: questions abound.
    21. (2006). ES: Chemotherapy-related amenorrhea in women with early breast cancer: the effect of paclitaxel or dose density. ASCO annual meeting proceedings (post-meeting edition).
    22. (2007). Fertility and adjuvant treatment in young women with breast cancer. Breast
    23. (2005). Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol
    24. (2005). Goldhirsch A: Breast International Group (BIG) 1–98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
    25. (2006). Gonadal damage and options for fertility preservation in female and male cancer survivors.
    26. (2002). Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. Anticancer Drugs
    27. (2006). H: Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.
    28. (2006). H: Reproduction beyond cancer: a message of hope for young women. Gynecol Oncol
    29. (1994). Hakulinen T: Survival of breast cancer patients after subsequent term pregnancy: ‘healthy mother effect’.
    30. (2000). Hartz AJ: A comparison of observational studies and randomized, controlled trials.
    31. (2004). Hortobagyi GN: Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer
    32. Hortobagyi GN: Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients.
    33. (2000). Horwitz RI: Randomized, controlled trials, observational studies, and the hierarchy of research designs.
    34. (2007). How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist
    35. (2005). Hudis C: Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer
    36. (2007). IE: Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). Breast Cancer Res Treat
    37. (2006). Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treat Rev
    38. (2005). Investigators: Adjuvant docetaxel for node-positive breast cancer.
    39. JF: Fertility preservation in female oncology patients.
    40. (1995). Khan-Dawood FS: Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin. Fertil Steril
    41. Langendonckt A: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet
    42. (1997). Mouridsen HAT: Should women be advised against pregnancy after breastcancer treatment? Lancet
    43. (1999). Müller BA: Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer
    44. (2006). Oktay K: Fertility preservation in young women undergoing breast cancer therapy. The Oncologist
    45. (2005). Oktay K: Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res
    46. (2007). Oktay K: Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
    47. (1996). Oleske DM, Cobleigh MA: Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
    48. (2006). Oncology recommendations on fertility preservation in cancer patients.
    49. (1999). Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radiochemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma
    50. (2002). Phase III trial comparing
    51. (2007). Pregnancy after breast cancer: population based study. BMJ
    52. (2005). Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy.
    53. (2003). Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer [abstract 50]. Proc Am Soc Clin Oncol
    54. (2006). Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol
    55. (2005). Prospects for oocyte banking and in vitro maturation.
    56. (2001). RD; International Breast Cancer Study Group: Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.
    57. (2008). Reimer T: Controversies in preservation of ovary function and fertility in patients with breast cancer. Breast Cancer Res Treat
    58. (2005). Reproduction after breast cancer: what advice do we have for our patients? [In German]. Zentralbl Gynakol
    59. (2001). RF: Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril
    60. (1998). RG: Cryopreservation of immature human oocytes and ovarian tissue: an emerging technology? Fertil Steril
    61. (1999). Risk of menopause during the first year after breast cancer diagnosis.
    62. (2003). Role of chemo-induced amenorrhea in premenopausal, node-positive, operable breast cancer patients: 9-year follow-up results of French Adjuvant Study Group (FASG) database [abstract]. Breast Cancer Res Treat
    63. (2005). Rosenwaks Z: Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation.
    64. (2003). Rosenwaks Z: Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod
    65. (2005). Runowicz CD: Preserving fertility after cancer.
    66. (1995). Rutqvist LE: Influence of prior and subsequent pregnancy on breast cancer prognosis.
    67. (2007). Sainsbury R: Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet
    68. (1995). Santen RJ: Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.
    69. (1998). Senn HJ: Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary
    70. (2001). Shah E: GnRH analogues in the management of early breast cancer. Breast Cancer Online
    71. (2000). SL: Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod
    72. (2006). Sukumvanich P: Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study.
    73. (2006). Swain SM: Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.
    74. (2007). The effect of a GnRH agonist on cryopreserved human ovarian grafts in severe combined immunodeficient mice. Reproduction
    75. (2007). The effect of cancer treatment on female fertility and strategies for preserving fertility.
    76. (1990). The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group. Ann Oncol
    77. (1989). The prognosis of patients who become pregnant after mastectomy for breast cancer. Int Surg
    78. (2007). The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
    79. Transient cooling to room temperature can cause irreversible disruption of the meiotic spindle in the human oocyte.
    80. (2006). Tsubura A: Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. In Vivo
    81. (2007). Tsubura A: N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats. Oncol Rep
    82. (1966). Tupper WR: Induction of ovulation with clomiphene citrate. A double-blind study. Fertil Steril
    83. (1996). Vassilaros S: Pregnancy and offspring after the appearance of breast cancer. Oncology
    84. (2003). Verschraegen C: GnRH antagonists in the treatment of gynecological and breast cancers. Endocr Relat Cancer
    85. WI: Fertilization of human oocytes following cryopreservation: normal karyotypes and absence of stray chromosomes. Hum Reprod
    86. (2006). Xenotransplantation of human ovarian tissue pieces in gonadotropin-stimulated SCID mice: the effect of ovariectomy. Anticancer Res

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.